Výsledky vyhledávání - "Yuta, Koshshino"

Risk factors for severe immune-related adverse events after first-line pembrolizumab monotherapy or combination chemotherapy for non-small-cell lung cancer

Autor: Toshiyuki, Sumi, Yuta, Koshshino, Motoki, Sekikawa, Yuta, Nagahisa, Keigo, Matsuura, Naoki, Shijubou, Koki, Kamada, Hiroki, Watanabe, Haruhiko, Michimata, Daiki, Nagayama, Yusuke, Tanaka, Yuichi, Yamada, Hirofumi, Chiba

Publikováno v: Investigational New Drugs. 40:1298-1305

Pembrolizumab treatment is associated with a favorable prognosis in patients with non-small-cell lung cancer (NSCLC). Here, we investigated the associations among pre-treatment clinical factors, baseline overall tumor burden, and development of sever

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680e41d602aefa9d5e6c156344efbd1e
https://doi.org/10.1007/s10637-022-01310-x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání